We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+19.03%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$3.79B
AUM Growth
+$689M
(+22%)
Cap. Flow
+$264M
Cap. Flow
% of AUM
6.96%
Top 10 Holdings %
Top 10 Hldgs %
76.38%
Holding
68
New
9
Increased
11
Reduced
6
Closed
16
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$97.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$85.3M |
| 3 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$61.7M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$49.6M |
| 5 |
Revolution Medicines
RVMD
|
+$45.3M |
Top Sells
| 1 |
Janux Therapeutics
JANX
|
+$45.3M |
| 2 |
Kymera Therapeutics
KYMR
|
+$23.6M |
| 3 |
Adicet Bio
ACET
|
+$20.5M |
| 4 |
Dyne Therapeutics
DYN
|
+$18M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$10.3M |
Sector Composition
| 1 | Healthcare | 99.92% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$447M
| $791M | 20.84% |
11,584,280
| – | – |
|
|
APLS
2
DELISTED
Apellis Pharmaceuticals
APLS
| $497M | 13.09% |
5,451,647
| – | – |
|
|
3
Sarepta Therapeutics
SRPT
$1.82B
| $419M | 11.05% |
3,660,798
+661,345
| +22% | +$85.3M |
|
|
LKFT
4
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $234M | 6.17% |
5,756,268
+1,511,623
| +36% | +$61.7M |
|
|
MORF
5
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $221M | 5.81% |
3,846,964
-2
| -0% | -$104 |
|
|
6
Revolution Medicines
RVMD
$39.2B
| $193M | 5.07% |
7,198,700
+1,846,517
| +35% | +$45.3M |
|
7
AnaptysBio
ANAB
$1.67B
| $153M | 4.03% |
7,521,024
| – | – |
|
8
Acadia Pharmaceuticals
ACAD
$4.46B
| $143M | 3.78% |
5,991,479
| – | – |
|
9
Xencor
XNCR
$1.11B
| $132M | 3.48% |
5,282,516
| – | – |
|
10
Zymeworks
ZYME
$1.82B
| $116M | 3.06% |
13,437,473
+3,350,000
| +33% | +$30M |
|
|
BPMC
11
DELISTED
Blueprint Medicines
BPMC
| $114M | 2.99% |
+1,798,300
| New | +$97.8M |
|
12
Arvinas
ARVN
$534M
| $99.7M | 2.63% |
4,017,788
+300,000
| +8% | +$7.72M |
|
|
SWTX
13
DELISTED
SpringWorks Therapeutics
SWTX
| $90.7M | 2.39% |
3,460,208
| – | – |
|
14
Kura Oncology
KURA
$1B
| $61.4M | 1.62% |
5,806,871
-831,500
| -13% | -$9.83M |
|
15
Relay Therapeutics
RLAY
$4.16B
| $52.3M | 1.38% |
4,163,824
| – | – |
|
|
16
Jazz Pharmaceuticals
JAZZ
$15B
| $45.7M | 1.2% |
+368,411
| New | +$49.6M |
|
17
Voyager Therapeutics
VYGR
$194M
| $44.1M | 1.16% |
3,851,507
| – | – |
|
|
CNTA
18
DELISTED
Centessa Pharmaceuticals
CNTA
| $34.8M | 0.92% |
5,618,779
| – | – |
|
19
Edgewise Therapeutics
EWTX
$4.29B
| $27.1M | 0.71% |
3,493,194
| – | – |
|
20
Oric Pharmaceuticals
ORIC
$1.11B
| $26.5M | 0.7% |
3,418,068
| – | – |
|
21
Atea Pharmaceuticals
AVIR
$381M
| $26.2M | 0.69% |
6,995,861
+811,000
| +13% | +$3.04M |
|
22
Nuvation Bio
NUVB
$2.04B
| $25M | 0.66% |
13,896,543
| – | – |
|
23
Alector
ALEC
$165M
| $24.4M | 0.64% |
4,056,548
| – | – |
|
24
Crinetics Pharmaceuticals
CRNX
$8.89B
| $24M | 0.63% |
1,330,263
| – | – |
|
25
Allogene Therapeutics
ALLO
$632M
| $22.3M | 0.59% |
4,488,200
| – | – |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM